Correspondence

Advice on Xylazine and 2-Methyl-AP-237

The government commissions the Advisory Council on the Misuse of Drugs (ACMD) to review the harms of Xylazine and 2-Methyl-AP-237.

• From: Home Office and Advisory Council on the Misuse of Drugs
• Published: 19 June 2023

This was published under the 2022 to 2024 Sunak Conservative government

Documents

Advice on Xylazine and 2-Methyl-AP-237

HTML

Details

The Minister for Crime, Policing and Fire has written to the ACMD to commission their advice on the potential harms of Xylazine and 2-Methyl-AP-237, including appropriate classification and scheduling under the Misuse of Drugs Act 1971 and associated Regulations.

The request for advice on Xylazine follows the first reported death associated with this drug in the UK. Advice on 2-Methyl-AP-237, a synthetic opioid, follows its addition to Schedule 1 of the Single Convention on Narcotic Drugs of 1961 at the 66th session of the United Nations Commission on Narcotic Drugs earlier this year.

Published 19 June 2023